European patent EP4570192A2 for implantable medical device

The European Patent Office has published European patent EP4570192A2 for an implantable medical device including a valve member, assigned to Cook Medical Technologies LLC. The patent was published on March 11, 2026, and covers designated states across Europe.

Glenoid component patent application filed by Howmedica Osteonics Corp

The European Patent Office has published a patent application (EP4537771A2) for a glenoid component filed by Howmedica Osteonics Corp. The application details include inventors and IPC classifications related to medical devices and prosthetics. The publication date is March 11, 2026.

European Patent for Prosthetic Heart Valve and Delivery Apparatus

The European Patent Office has published patent application EP4552622A2 for a prosthetic heart valve and delivery apparatus, with applicants Edwards Lifesciences Corporation. The patent is designated for several European states and is scheduled for publication on March 11, 2026.

PHMSA Compromise Order with Certificate of Service

The Pipeline and Hazardous Materials Safety Administration (PHMSA) has issued a Compromise Order and Certificate of Service related to case number 24-0240-SH-EA concerning FHS Retail LLC. This order signifies a resolution to a compliance matter involving hazardous materials transportation.

Maryland AG Seeks Records on Baltimore ICE Detention Facility Conditions

The Maryland Attorney General has filed a motion for summary judgment against U.S. Immigration and Customs Enforcement (ICE) and the Department of Homeland Security (DHS) to compel the production of records concerning alleged dangerous and inhumane conditions at the Baltimore ICE detention facility. The lawsuit stems from an investigation into potential civil rights violations.

Maryland AG Statement on Meta and YouTube Verdicts Harming Children

Maryland Attorney General Anthony G. Brown issued a statement following landmark verdicts against Meta and YouTube for designing social media platforms that exploit children and harm their mental health. The verdicts are seen as a reckoning for an industry that prioritizes profit over young people's well-being, and Maryland is part of similar multistate litigation.

DEA Classifies Bromazolam as Schedule I Controlled Substance

The U.S. Drug Enforcement Administration (DEA) has classified bromazolam, a designer benzodiazepine, as a Schedule I controlled substance nationwide. This action, requested by a coalition of state attorneys general, aligns bromazolam with substances like heroin and LSD and empowers law enforcement to address its distribution.

FCC Removes Obsolete Rules to Improve Network Deployment

The FCC has removed a set of obsolete rules to streamline network deployment and reduce regulatory burdens. This action is part of an ongoing effort to cut red tape and modernize telecommunications infrastructure.

FCC Strengthens Protections for Public Funds

The FCC has adopted new rules to strengthen protections for public funds, particularly concerning news organizations. The adopted date and release date for these new protections were March 26, 2026.

FCC Plan for Spectrum Access for Space Missions

The FCC has adopted a plan to ensure reliable spectrum access for cutting-edge space missions, including orbital laboratories and in-space repairs. This initiative aims to support the growing commercial space sector by providing clear guidelines for spectrum use.